A citation-based method for searching scientific literature

Brian Finan, Tao Ma, Nickki Ottaway, Timo D Müller, Kirk M Habegger, Kristy M Heppner, Henriette Kirchner, Jenna Holland, Jazzminn Hembree, Christine Raver, Sarah H Lockie, David L Smiley, Vasily Gelfanov, Bin Yang, Susanna Hofmann, Dennis Bruemmer, Daniel J Drucker, Paul T Pfluger, Diego Perez-Tilve, Jaswant Gidda, Louis Vignati, Lianshan Zhang, Jonathan B Hauptman, Michele Lau, Mathieu Brecheisen, Sabine Uhles, William Riboulet, Emmanuelle Hainaut, Elena Sebokova, Karin Conde-Knape, Anish Konkar, Richard D DiMarchi, Matthias H Tschöp. Sci Transl Med 2013
Times Cited: 326



Pia K Nørregaard, Maria A Deryabina, Pernille Tofteng Shelton, Jacob U Fog, Jens R Daugaard, Per-Olof Eriksson, Lone F Larsen, Lene Jessen. Diabetes Obes Metab 2018
Times Cited: 56




List of shared articles



Times cited

Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?
Tito Borner, Ian C Tinsley, Robert P Doyle, Matthew R Hayes, Bart C De Jonghe. Br J Pharmacol 2022
6

The incretin/glucagon system as a target for pharmacotherapy of obesity.
Stefano Del Prato, Baptist Gallwitz, Jens Juul Holst, Juris J Meier. Obes Rev 2022
4

The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial Diseases.
Tingkai Chen, Tianyu Sun, Yaoyao Bian, Yuqiong Pei, Feng Feng, Heng Chi, Yuan Li, Xu Tang, Shenghu Sang, Chenxi Du,[...]. J Med Chem 2022
0


Regulation of feeding and therapeutic application of bioactive peptides.
Hiroaki Ueno, Weidong Zhang, Masamitsu Nakazato. Pharmacol Ther 2022
0


Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice.
Patrick J Knerr, Stephanie A Mowery, Jonathan D Douros, Bhavesh Premdjee, Karina Rahr Hjøllund, Yantao He, Ann Maria Kruse Hansen, Anette K Olsen, Diego Perez-Tilve, Richard D DiMarchi,[...]. Mol Metab 2022
1



Nutrient-Induced Cellular Mechanisms of Gut Hormone Secretion.
Van B Lu, Fiona M Gribble, Frank Reimann. Nutrients 2021
15

The Role of GIP in the Regulation of GLP-1 Satiety and Nausea.
Matthew R Hayes, Tito Borner, Bart C De Jonghe. Diabetes 2021
5

GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Based Therapies in Treating Metabolic Disorders.
Ricardo J Samms, Kyle W Sloop, Fiona M Gribble, Frank Reimann, Alice E Adriaenssens. Diabetes 2021
7

Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment.
Maria Chiara Pelle, Michele Provenzano, Isabella Zaffina, Roberta Pujia, Federica Giofrè, Stefania Lucà, Michele Andreucci, Angela Sciacqua, Franco Arturi. Life (Basel) 2021
3

Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists?
Elizabeth A Killion, Shu-Chen Lu, Madeline Fort, Yuichiro Yamada, Murielle M Véniant, David J Lloyd. Endocr Rev 2020
28

Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease.
Sebastian M Heimbürger, Natasha C Bergmann, Robert Augustin, Lærke S Gasbjerg, Mikkel B Christensen, Filip K Knop. Peptides 2020
11





Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates.
Patrick J Knerr, Stephanie A Mowery, Brian Finan, Diego Perez-Tilve, Matthias H Tschöp, Richard D DiMarchi. Peptides 2020
21